We are currently setting up a research and clinical structure to offer cellular treatment for patients with cancer with a strong pre-clinical and clinical interaction i) to better understand the tumor-host relationshipii) to map the patients ‘private’ mutational burden and iii) to identify the best immunological strategy to fight off cancer using molecular methodsgene transferbiological therapy guided by imaging technologies. Data from infectious diseases aid to better understand the tumor-host relationship and aid to gauge biologically and clinically relevant HDTs (host directed therapy) concepts.

Clinical Immunology is at the crossroad where biologically and clinically relevant research intersect with clinical practice in infectious disease and canceryet there is often not a structured cross-fertilizing interface between these disciplines. To overcome thisthe Immunotherapy/ImmunoSurgery Lab is part of a clinical research consortium – Against-Cancer-And-Infection – with the aim to foster fruitful collaborations in research and clinical developments in both areasinfectious disease and cancer.